These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26503818)

  • 1. Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis.
    Zhang C; Zhang Y; Cai J; Chen M; Song L
    Pharmacogenomics J; 2017 Jan; 17(1):92-97. PubMed ID: 26503818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype.
    Zhang Y; Chen M; Chen J; Wu Z; Yu S; Fang Y; Zhang C
    Psychopharmacology (Berl); 2014 May; 231(10):2211-8. PubMed ID: 24448899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics.
    Yang L; Chen J; Li Y; Wang Y; Liang S; Shi Y; Shi S; Xu Y
    World J Biol Psychiatry; 2016 Sep; 17(6):467-74. PubMed ID: 26982812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results.
    Zhang Y; Chen M; Wu Z; Chen J; Yu S; Fang Y; Zhang C
    PLoS One; 2013; 8(8):e72652. PubMed ID: 23967328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between SREBF2 gene polymorphisms and metabolic syndrome in clozapine-treated patients with schizophrenia.
    Yang L; Chen J; Liu D; Yu S; Cong E; Li Y; Wu H; Yue Y; Zuo S; Wang Y; Liang S; Shi Y; Shi S; Xu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():136-41. PubMed ID: 25201120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics.
    Bai YM; Chen TT; Liou YJ; Hong CJ; Tsai SJ
    Schizophr Res; 2011 Feb; 125(2-3):179-86. PubMed ID: 21185157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
    Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
    Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
    Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the diagnostic ability of inflammatory markers in metabolic syndrome.
    Meng G; Zhu Q; Shao J; Zhang Q; Liu L; Wu H; Xia Y; Bao X; Gu Y; Wang H; Shi H; Sun S; Wang X; Zhou M; Jia Q; Wang G; Song K; Wu Y; Niu K
    Clin Chim Acta; 2017 Dec; 475():1-6. PubMed ID: 28974361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia.
    Sagud M; Vlatkovic S; Svob Strac D; Sviben M; Zivkovic M; Vilibic M; Vuksan-Cusa B; Mihaljevic-Peles A; Pivac N
    Compr Psychiatry; 2018 Apr; 82():115-120. PubMed ID: 29477703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia.
    Bai YM; Chen JY; Yang WS; Chi YC; Liou YJ; Lin CC; Wang YC; Lin CY; Su TP; Chou P
    J Clin Psychiatry; 2007 Dec; 68(12):1834-9. PubMed ID: 18162013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between brain-derived neurotrophic factor and metabolic syndrome in patients with chronic schizophrenia: A systematic review.
    Kalejahi P; Kheirouri S; Noorazar SG; Sanayei M
    Neuropeptides; 2021 Jun; 87():102135. PubMed ID: 33812160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia.
    Eskelinen S; Sailas E; Joutsenniemi K; Holi M; Suvisaari J
    Nord J Psychiatry; 2015 Jul; 69(5):339-45. PubMed ID: 25981178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants of microsomal triglyceride transfer protein (MTTP) are associated with metabolic syndrome in schizophrenic patients treated with atypical antipsychotics.
    Liou YJ; Tsai SJ; Wang YC; Bai YM; Hong CJ
    J Clin Psychopharmacol; 2013 Jun; 33(3):313-8. PubMed ID: 23609384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of apolipoprotein A5 gene variants with metabolic syndrome in Tunisian population.
    Kefi R; Hechmi M; Dallali H; Elouej S; Jmel H; Halima YB; Nagara M; Chargui M; Fadhel SB; Romdhane S; Kamoun I; Turki Z; Abid A; Bahri S; Bahlous A; Gomis R; Baraket A; Grigorescu F; Normand C; Jamoussi H; Abdelhak S
    Ann Endocrinol (Paris); 2017 Jul; 78(3):146-155. PubMed ID: 28624160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants impacting metabolic outcomes among people on clozapine: a systematic review and meta-analysis.
    Suetani RJ; Siskind D; Reichhold H; Kisely S
    Psychopharmacology (Berl); 2017 Oct; 234(20):2989-3008. PubMed ID: 28879574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome.
    Phillips CM; Goumidi L; Bertrais S; Ferguson JF; Field MR; Kelly ED; Peloso GM; Cupples LA; Shen J; Ordovas JM; McManus R; Hercberg S; Portugal H; Lairon D; Planells R; Roche HM
    Am J Clin Nutr; 2009 Dec; 90(6):1665-73. PubMed ID: 19828715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Determinants of Clozapine-Induced Metabolic Side Effects.
    Vasudev K; Choi YH; Norman R; Kim RB; Schwarz UI
    Can J Psychiatry; 2017 Feb; 62(2):138-149. PubMed ID: 27681143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
    Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
    Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing Prevalence and Correlates of Metabolic Syndromes Between Chlorpromazine and Clozapine: A 10-year Retrospective Study of a Male Chinese Cohort.
    Xing M; Sheng J; Cui M; Su Y; Zhang C; Chen X; Fang Y; Cui D; Li Z
    Curr Neuropharmacol; 2022; 20(10):1969-1977. PubMed ID: 35236263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.